60d FRN - published

jspears on DSK121TN23PROD with NOTICES1

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
Management Lead, National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention, CDC, 1600 Clifton Road NE,
Mailstop US8–6, Atlanta, Georgia
30329–4027, Telephone: (404) 639–
3423; Email: MCondit@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
persons who have expertise and
qualifications necessary to contribute to
the accomplishments of the council’s
objectives. Nominees will be selected on
the basis of their expertise in public
health, epidemiology, immunology,
infectious diseases, pulmonary disease,
pediatrics, tuberculosis, microbiology,
or preventive health care delivery.
Federal employees will not be
considered for membership. Members
may be invited to serve for up to fouryear terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET
objectives.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACET membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2023, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE nominees must be
U.S. citizens and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items to be considered:
D Current curriculum vitae, including
complete contact information

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

(telephone numbers, mailing address,
and email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (i.e., CDC,
NIH, FDA, etc.).
Nominations may be submitted by the
candidate himself or herself or by a
person or organization recommending
the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03036 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1132; Docket No. CDC–2022–
0023]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Performance Progress and
Monitoring Report (PPMR). The PPMR
is designed to allow CDC to collect
information related to CDC Awardee’s
budgets, strategies and activities, and
the process and outcome performance

SUMMARY:

PO 00000

Frm 00035

Fmt 4703

Sfmt 4703

8261

measures outlined by the cooperative
agreement programs, in order to
evaluate partnerships and the work that
is done on behalf of CDC.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0023 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,

E:\FR\FM\14FEN1.SGM

14FEN1

8262

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Performance Progress and Monitoring
Report (PPMR) (OMB Control No. 0920–
1132, Exp. 10/31/2022)—Extension—
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Each year, approximately 80% of the
CDC’s budget is distributed via
contracts, grants and cooperative
agreements, from the Office of Financial
Resources (OFR) to partners (Awardees)
throughout the world in an effort to
promote health, prevent disease, injury
and disability and prepare for new
health threats. OFR is responsible for
the stewardship of these funds while
providing excellent, professional

outlined for each of the CDC Awardees.
Collection and reporting of the
information will occur in an efficient,
standardized, and user-friendly manner
that will generate a variety of routine
and customizable reports. The PPMR
will allow each Awardee to summarize
activities and progress towards meeting
performance measures and goals over a
specified time period specific to each
award. CDC will also have the capacity
to generate reports that describe
activities across multiple Awardees. In
addition, CDC will use the information
collection to respond to inquiries from
HHS, Congress and other stakeholder
inquiries about program activities and
their impact. The current submission
process allows Awardees to submit a
completed PDF version of the PPMR by
uploading it to www.grants.gov, or
directly to the programs at CDC that will
be performing the evaluation.
This Extension request is being
submitted to allow CDC to continue
collection of this valuable information
from Awardees for an additional three
years. There are no anticipated changes
to the information collection
instruments or associated burden at this
time. CDC requests OMB approval for an
estimated 13,014 annual burden hours.
There is no cost to respondents other
than their time.

services to our partners and
stakeholders.
Currently, CDC uses the Performance
Progress and Monitoring Report (PPMR,
OMB Control No. 0920–1132,
Expiration: 10/31/2022), a set of
progress reporting forms for NonResearch awards to collect information
semi-annually from Awardees regarding
the progress made over specified time
periods on CDC funded projects. The
PPMR was originally modified from SF–
PPR (OMB Control No. 0970–0406,
Expiration: 10/31/2015), a similar
progress report that was owned by the
Administration for Children and
Families (ACF) within the Department
of Health and Human Services (HHS).
The PPMR was created by CDC to
provide an agency-wide collection tool
that would be able to obtain data on the
progress of CDC Awardees for the
purposes of evaluation, and to bring the
Awardee reporting procedure into
compliance with the Paperwork
Reduction Act (PRA).
The information collected enables the
accurate, reliable, uniform, and timely
submission to CDC of each Awardee’s
work plans and progress reports,
including strategies, activities and
performance measures. The information
collected by the PPMR is designed to
align with, and support the goals

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

CDC Award Recipients .....................

Performance Progress and Monitoring Report (PPMR—Att. A–F).
Performance Progress and Monitoring Report (PPMR—Att. G).
Performance Progress and Monitoring Report (PPMR—Att. A–F).

CDC Award Recipients .....................
NHSS Award Recipients ...................
Total ...........................................

Number of
responses per
respondent

Number of
respondents

Type of respondent

...........................................................

1

2

10,400

1,632

1

5/60

136

60

1

41

2,478

........................

........................

........................

13,014

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2022–03080 Filed 2–11–22; 8:45 am]

[Docket No. FDA–2022–N–0083]

Food and Drug Administration

BILLING CODE 4163–18–P

jspears on DSK121TN23PROD with NOTICES1

Food and Drug Administration Hiring
and Retention Final Assessment;
Public Meeting; Request for Comments
Food and Drug Administration,

HHS.
Notice of public meeting;
request for comments.

ACTION:

The Food and Drug
Administration (FDA, the Agency, or
we) is holding a virtual meeting entitled

SUMMARY:

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

PO 00000

Frm 00036

Fmt 4703

Total burden
(in hours)

5,200

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.

AGENCY:

Average
burden per
response
(in hours)

Sfmt 4703

‘‘FDA Hiring and Retention Final
Assessment’’ and an opportunity for
public comment. The topic to be
discussed is the FDA Hiring and
Retention Final Assessment, which was
an independent assessment performed
by Booz Allen Hamilton, published on
December 10, 2021. This public meeting
will take place virtually due to
extenuating circumstances and will be
held by webcast only.
The public meeting will be held
on March 15, 2022, from 9 a.m. to 12
noon Eastern Time. Submit either
electronic or written comments on this
public meeting by May 16, 2022. See the

DATES:

E:\FR\FM\14FEN1.SGM

14FEN1